Brief Introduction of Shandong Freda Pharmaceutical Group Company

Shandong Freda Pharmaceutical Group Co., Ltd. was established in June1April 993 17, formerly known as Shandong Biochemical Pharmaceutical Company, and is affiliated to Shandong Commercial Group Co., Ltd., which is a modern large-scale high-tech industrial group integrating science, industry and trade. Shandong Freda Pharmaceutical Group Co., Ltd., relying on Shandong Academy of Pharmaceutical Sciences and based on the product development of drugs, health foods and cosmetics related to human health, has formed a comprehensive pharmaceutical enterprise group integrating science, industry and trade. With independent intellectual property technology, the pharmaceutical group has successively established a number of high-tech enterprises, such as Shandong Doctor Lun (formerly) Freda Pharmaceutical Co., Ltd., Shandong Freda Biomedical Co., Ltd., Shandong Mingren Freda Pharmaceutical Co., Ltd., Shandong Freda Bioengineering Co., Ltd. and Shandong Freda Biotechnology Co., Ltd., whose industries involve drugs, health foods, cosmetics, medical devices and raw materials. It owns many well-known brands such as Runshu, Runjie, Spat, Akihito and Yilian. 20 1 1 year, the sales revenue of Freda Pharmaceutical Group is 1.73 billion yuan, and the profit and tax is 368 million yuan. Shandong Doctor Lun Freda Pharmaceutical Co., Ltd. has developed into the largest production base of ophthalmic drugs in China, and its products have occupied 20% of the domestic market share of ophthalmic drugs. Shandong Freda Biomedical Co., Ltd. relies on the technical advantages of producing hyaluronic acid by fermentation, and its products not only occupy the main market share in the domestic market, but also are exported to Japan, the United States, Europe, South Korea and other international markets.